FDA Approves Zevaskyn for Treating RDEB-Related Blistering Wounds Dr. Kamal Kant Kohli5 May 2025 9:15 AM ISTThe U.S. Food and Drug Administration (FDA) has approved prademagene zamikeracel (Zevaskyn) for the treatment of blistering wounds caused by recessive...
Xyngari found beneficial for Moderate to Severe Acne in Phase 3 Trial Dr. Kamal Kant Kohli1 April 2025 8:45 PM ISTTopline results were announced from a phase 3 trial evaluating Xyngari (formerly DMT310), a novel topical treatment derived from a freshwater sponge....
New treatment option for psoriasis discovered Dr. Kamal Kant Kohli24 March 2025 9:00 PM ISTPsoriasis is one of the most common chronic inflammatory skin diseases, affecting around 250,000 people in Austria. While previous treatment...
Human papillomavirus infection may increase risk of new-onset hidradenitis suppurativa, suggests study Dr Riya Dave27 Feb 2025 8:30 PM ISTResearchers have found that human papillomavirus infection is more likely to be found in those with hidradenitis suppurativa (HS), an inflammatory...
Death of infant due to rare genetic disease affecting skin Anshika Mishra15 July 2024 5:44 PM ISTA Boston mother has opened up about the devastating loss of her two-month-old son, Felix Jean, who succumbed to a rare genetic condition called...
Exclusive breastfeeding for four months protects against psoriasis development through early adulthood: Study Medha Baranwal29 Feb 2024 12:30 AM ISTSweden: A recent study published in the British Journal of Dermatology for the first time has highlighted the potential role of early diet on...
Novartis wins USFDA nod for Cosentyx to treat hidradenitis suppurativa in adults Ruchika Sharma1 Nov 2023 2:00 PM ISTBasel: Novartis has announced that the US Food and Drug Administration (FDA) has approved Cosentyx (secukinumab) to treat moderate to severe...
Medical Bulletin 23/September/2023 Isra Zaman23 Sept 2023 3:15 PM ISTHere are the top medical news of the day:Patients with severe psoriasis are at a higher risk for heart disease, study confirmsIn the largest study to...
Patients with severe psoriasis are at a higher risk for heart disease, study confirms Isra Zaman23 Sept 2023 9:30 AM ISTIn the largest study to date exploring the relationship between severe psoriasis and coronary microvascular dysfunction, researchers have found...
Novel Calcipotriene and Betamethasone Dipropionate PAD cream effective and safe treatment of Psoriasis Dr.Niharika Harsha B1 Aug 2023 9:00 AM ISTNew research revealed that a fixed-dose combination of the novel calcipotriene (CAL) and betamethasone dipropionate PAD cream is highly efficacious...
Doctors at Panipat Hospital give new lease of life to newborn suffering from Collodion Syndrome MD Bureau11 April 2023 5:00 PM ISTHaryana: A baby born prematurely with a rare and potentially life-threatening skin disease has been given a new lease of life by doctors at Panipat,...
Psoriasis drug Apremilast incredibly promising treatment for alcohol use disorder Dr. Kamal Kant Kohli24 Feb 2023 9:45 AM ISTApremilast is an FDA-approved anti-inflammatory medication used to treat psoriasis and psoriatic arthritis. Researchers have found in a new study...
